Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2024-01-08 00:00:00 ET · period of report 2024-01-04 · accession 0001610717-24-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-08 | 2024-01-04 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $2.92 | -2,275 | 86.1K | -3% | -$6,643 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | F | D | 2,275 | $2.92 | 86,131 | D | — | — | (F1) Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. |